Asymchem Laboratories (Tianjin) Co., Ltd. (06821.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 164.60

From 52W high−4.19%

Volume907100.00

Market capHKD 57.10B

P/E (TTM)46.5x

P/S (TTM)6.9x

Div yield0.95%

Key dataSep 18, 2026

Open

HKD 164.60

From 52W high

−4.19%

Volume

907100.00

Market cap

HKD 57.10B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

29.8x

P/E (TTM)

46.5x

RSI (14)

65.3

MomentumView details →

1D Return

−2.84%

YTD Return

+121.35%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

46.5x

EV/EBITDA

29.8x

EV/Sales

6.1x

P/S (TTM)

6.9x

P/B (TTM)

2.8x

ProfitabilityView details →

Gross Margin

40.51%

Net Margin

14.67%

EBITDA Margin

20.34%

ROE (TTM)

5.83%

ROA (TTM)

4.97%

Asset Turnover

0.34x

GrowthView details →

Revenue YoY

+11.99%

EPS YoY

−1.69%

FCF YoY

−7.31%

Revenue CAGR 3Y

−13.36%

EPS CAGR 3Y

−29.28%

EBITDA YoY

+14.47%

MomentumView details →

1D Return

−2.84%

YTD Return

+121.35%

1Y Return

+59.59%

RSI (14)

65.3

vs 50D SMA

+24.17%

vs 200D SMA

+60.36%

Capital & dividendView details →

Debt/Equity

0.03x

Current Ratio

4.56x

Quick Ratio

3.76x

Div Yield

0.95%

Div Rate

HKD 1.50

Div Growth 1Y

+24.39%

EarningsView details →

EPS (Actual)

HKD 0.35

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

HKD 0.00

Avg Surprise (4Q)

—

Rev Surprise

−6.71%

Financials snapshotView financials →

Revenue (TTM)

7.05B

Net Income (TTM)

1.03B

Op. CF (TTM)

1.59B

Next earningsNov 4, 2026 →

Latest newsMore news →

Asymchem Laboratories announced its first-half 2026 results: revenue of 3.607 billion yuan, up 13.13% year-on-year, and net profit attributable to shareholders of 520 million yuan, down 15.71% from 617 million yuan in the same period of 2025.27d ago

Chinese innovative drug and CXO stocks rebounded strongly, with the CSI Innovative Drug Industry Index rising 28.04% since June 9, 2026, and several stocks hitting daily limits on August 7, 2026.44d ago

Similar companies

Encell Co. Ltd.456070.KQ Pharmaron Beijing Co., Ltd.03759.HK Moderna, Inc.MRNA argenx SEARGX Amicogen, Inc.092040.KQ 艾力斯688578.SH Find similar companies →

Latest newsMore news →

Asymchem Laboratories announced its first-half 2026 results: revenue of 3.607 billion yuan, up 13.13% year-on-year, and net profit attributable to shareholders of 520 million yuan, down 15.71% from 617 million yuan in the same period of 2025.27d ago Chinese innovative drug and CXO stocks rebounded strongly, with the CSI Innovative Drug Industry Index rising 28.04% since June 9, 2026, and several stocks hitting daily limits on August 7, 2026.44d ago